CAS 1869912-39-9

AZD5153

CAS: 1869912-39-9

AZD5153

Purity: ≥98%

Molecular weight: 479.57g/mol

Ref: 54-BUP02759

AZD5153

CAS: 1869912-39-9

AZD5153 is an orally active and selective BET/BRD4 bromodomain inhibitor with an IC50 value of 1.7nM for BRD4.

Formula: C₂₅H₃₃N₇O₃

Purity: 99.25%

Color and Shape: Solid

Molecular weight: 479.57

Ref: TM-T3504L

AZD-5153

CAS: 1869912-39-9

AZD-5153 is a drug that inhibits the activity of epidermal growth factor receptor (EGFR). It has been shown to have potent anticancer effects in cellular and animal models. AZD-5153 has been shown to inhibit tumor growth by blocking EGFR signaling, which prevents the proliferation of cancer cells. This drug also blocks the production of inflammatory cytokines, such as IL-6 and TNF-α, which may be responsible for its anti-inflammatory and immunosuppressive effects. AZD-5153 has also been shown to inhibit HIV infection in vivo models. This drug is not active against other receptors, such as HER2 or VEGFR2.

Formula: C₂₅H₃₃N₇O₃

Purity: Min. 95%

Molecular weight: 479.59 g/mol

Ref: 3D-UZC91239